A detailed history of Fmr LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Fmr LLC holds 7,514,010 shares of MORF stock, worth $428 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,514,010
Previous 7,505,584 0.11%
Holding current value
$428 Million
Previous $264 Million 3.1%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$26.12 - $34.07 $220,087 - $287,073
8,426 Added 0.11%
7,514,010 $256 Million
Q1 2024

May 13, 2024

BUY
$26.64 - $40.31 $19.2 Million - $29.1 Million
722,281 Added 10.65%
7,505,584 $264 Million
Q4 2023

Feb 13, 2024

BUY
$19.95 - $31.0 $5.21 Million - $8.1 Million
261,243 Added 4.01%
6,783,303 $196 Million
Q3 2023

Nov 13, 2023

SELL
$21.33 - $59.42 $7.5 Million - $20.9 Million
-351,754 Reduced 5.12%
6,522,060 $149 Million
Q2 2023

Aug 11, 2023

BUY
$34.33 - $62.11 $32.4 Million - $58.6 Million
943,699 Added 15.91%
6,873,814 $394 Million
Q1 2023

May 11, 2023

BUY
$26.01 - $48.69 $3.83 Million - $7.17 Million
147,242 Added 2.55%
5,930,115 $223 Million
Q4 2022

Feb 13, 2023

BUY
$24.14 - $30.37 $273,192 - $343,697
11,317 Added 0.2%
5,782,873 $155 Million
Q3 2022

Nov 10, 2022

BUY
$22.23 - $33.37 $694,265 - $1.04 Million
31,231 Added 0.54%
5,771,556 $163 Million
Q2 2022

Aug 12, 2022

BUY
$19.74 - $43.01 $3.45 Million - $7.51 Million
174,690 Added 3.14%
5,740,325 $125 Million
Q1 2022

May 13, 2022

BUY
$36.25 - $52.02 $775,786 - $1.11 Million
21,401 Added 0.39%
5,565,635 $223 Million
Q4 2021

Feb 14, 2022

BUY
$43.27 - $65.72 $3.31 Million - $5.03 Million
76,572 Added 1.4%
5,544,234 $263 Million
Q3 2021

Nov 15, 2021

BUY
$53.61 - $67.5 $1.9 Million - $2.4 Million
35,508 Added 0.65%
5,467,662 $310 Million
Q2 2021

Aug 13, 2021

BUY
$45.13 - $64.99 $245 Million - $353 Million
5,432,154 New
5,432,154 $312 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.